<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The development of treatments targeting vascular endothelial growth factor (VEGF) over the past 10 years has seen a dramatic reduction in vision loss from advanced AMD. However, with long-term treatment, many patients with AMD continue to lose vision [
 <xref rid="B186-marinedrugs-17-00374" ref-type="bibr" class="xref">186</xref>]
</p>
